A Community Collaboration Between IU Health and St. Vincent
Current Studies & Research
The interFACE Lab

The interFACE Lab The Interactive and Functional Assessment of Communication and Emotion (InterFACE) Center is a natural observation laboratory designed to research emotional and behavioral deficits in people with neurological,… Read More

TrackTBI

TrackTBI Investigator: Richard Rodgers, MD TRACK-TBI:  The multicenter Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) study aims to improve success of clinical trial design through the collection and analysis of… Read More

Training to Reconnect with emotional awareness therapy

Training to Reconnect with emotional awareness therapy (TREAT) Investigators: Dawn Neumann, Flora Hammond The purpose of this study is to teach participants with traumatic brain injury to develop better emotional… Read More

Avanir Study

Avanir Study Sheryl Katta-Charles MD, Principal Investigator A Phase 2, multicenter, randomized, double-blind, placebo-controlled study to assess the efficacy, safety and tolerability or AVP-786 (deudextromethorphan hydrobromide [d6-DM]/quinidine sulfate [Q]) for… Read More

Monitoring Safety and Training in Patients with Spinal Cord Injuries

Long-Term, Prospective, Non-Interventional Study Monitoring Safety and Training in Patients with Spinal Cord Injuries and Their Trained Companions Recently Initiated with the ReWalk™ Personal Device. Flora Hammond, MD (PI), funded… Read More

SEE ALL RESEARCH
BACK
Multi-State Outbreak of Meningitis Following Epidural Steroid Injections of Methylprednisolone October 5th, 2012

Multi-State Outbreak of Meningitis Following Epidural Steroid Injections of Methylprednisolone

This communication is being sent in response to the meningitis outbreak being reported on the news.  This outbreak is related to epidural steroid injections done with a compounded medication.  Please be advised that the RHI clinic does not utilize the compounded medication that is in question with this outbreak.

Please share this information as appropriate and needed.  Please direct any questions or concerns regarding this update to the Outpatient Clinic 329.2525 or to Infection Prevention 329.2201.